Microbial Therapeutics Designed for Infant Health.

Area of Science:

• Microbiology
• Pediatrics
• Gastroenterology

Background:

• The gut microbiome plays a vital role in infant health.
• Factors like genetics, delivery mode, feeding, and antibiotics significantly impact the developing infant gut microbiome.
• A healthy infant gut microbiome, considered the 'gold standard,' is typically seen in term, vaginally born, exclusively breastfed infants with no antibiotic exposure.

Purpose of the Study:

• To review the beneficial effects of probiotic and prebiotic treatments in early life.
• To emphasize conditions that negatively affect microbial colonization at birth.
• To highlight the importance of prebiotics, like breastmilk, in supporting a healthy gut microbiome.

Main Methods:

• This mini-review synthesizes existing research on early life gut microbiome development.
• It focuses on the impact of various factors on microbial colonization.
• The review examines the role of prebiotics and probiotics in managing gut health.

Main Results:

• Breastmilk serves as a natural prebiotic, promoting beneficial microbial growth.
• Altered gut microbiomes in early life are linked to disorders like necrotizing enterocolitis, obesity, and autism.
• Probiotic and prebiotic interventions show promise in preventing gastrointestinal microbial disturbances.

Conclusions:

• Optimizing the early life gut microbiome is essential for long-term health.
• Probiotic and prebiotic therapies are valuable tools for supporting infant gut health.
• Understanding factors influencing microbial colonization is key to preventing early life disorders.